De-escalation approaches in the treatment of women with HER2 positive breast cancer need to be personalised, according to Dr. Carmen
Continue reading »
mypharmacynews.com
Home »
De-escalation approaches in the treatment of women with HER2 positive breast cancer need to be personalised, according to Dr. Carmen
Continue reading »(HealthDay)—A de-escalation from triple therapy to indacaterol/glycopyrronium may lead to a small reduction in lung function in non-frequently exacerbating patients
Continue reading »